SYK

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Stryker Corp.

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
CEO
Kevin Lobo
Employees
2021
Headquarters

2825 Airview Blvd
Portage, Michigan 49002-1802
Phone: 12693892600
www.stryker.com

News

Q4 —…—‘ Stryker Corp Earnings Call Transcript
Feb 11, 2024 10:55am

Q4 2023 Stryker Corp Earnings Call Transcript


Source:GuruFocus
Board Member Of Stryker Makes $100.35M Sale
Feb 08, 2024 15:01pm

Disclosed on February 7, Ronda E Stryker , Board Member at Stryker (NYSE: SYK ), executed a substantial insider sell as per the latest SEC filing. What Happened: Stryker''s recent move involves selling 293,442 shares of Stryker . This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value is $100,349,380. The latest update on Thursday morning shows Stryker shares down by 0.46%, trading at $341.14. Delving into Stryker''s Background Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker''s total revenue currently comes from outside the United States.


Source:Benzinga
Witnessing An Insider Decision, Yin C Becker Exercises Options Valued At $2.01M At Stryker
Feb 08, 2024 15:01pm

A significant insider transaction involving the exercise of company stock options was reported on February 7, by Yin C Becker , VP at Stryker (NYSE: SYK ), as per the latest SEC filing. What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday revealed that Becker, VP at Stryker in the Health Care sector, exercised stock options for 8,060 shares of SYK stock. The exercise price of the options was $93.06 per share. Stryker shares are currently trading down by 0.0%, with a current price of $342.72 as of Thursday morning. This brings the total value of Becker''s 8,060 shares to $2,012,259. Get to Know Stryker Better Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment.


Source:Benzinga
Stryker Corp (SYK)''s Winning Formula: Financial Metrics and Competitive Strengths
Feb 07, 2024 15:03pm

Stryker Corp (SYK)''s Winning Formula: Financial Metrics and Competitive Strengths


Source:GuruFocus
Board Member At Stryker Exercises Options Worth $1.13M
Feb 07, 2024 15:02pm

Highlighted on February 6, it was unveiled in an SEC filing that Stryker, Board Member at Stryker (NYSE: SYK ), executed a significant transaction involving the exercise of company stock options. What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission , Stryker, Board Member at Stryker, executed a strategic derivative sale. This involved exercising stock options for 4,355 shares of SYK, resulting in a transaction value of $1,125,440. Currently, Stryker shares are trading down 0.06%, priced at $339.56 during Wednesday''s morning. This values Stryker''s 4,355 shares at $1,125,440. Unveiling the Story Behind Stryker Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment.


Source:Benzinga
Insider Move: Allan C Golston Exercises Options, Realizing $1.11M At Stryker
Feb 07, 2024 15:02pm

Allan C Golston , Director at Stryker (NYSE: SYK ), reported a large exercise of company stock options on February 6, according to a new SEC filing. What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission , Golston, Director at Stryker, executed a strategic derivative sale. This involved exercising stock options for 4,570 shares of SYK, resulting in a transaction value of $1,111,104. Currently, Stryker shares are trading down 0.06%, priced at $339.56 during Wednesday''s morning. This values Golston''s 4,570 shares at $1,111,104. Delving into Stryker''s Background Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment.


Source:Benzinga
Stryker: Rerating Higher
Feb 07, 2024 13:19pm

No summary available.


Source:Seeking Alpha
Stryker: A Dividend Growth Powerhouse I''d Like To Own
Feb 02, 2024 13:00pm

Stryker''s net sales and adjusted diluted EPS both climbed at double-digit clips in Q4. Read why SYK stock is a hold.


Source:Seeking Alpha
Stryker Stock Sees Relative Strength Rating Jump To 84
Feb 01, 2024 20:03pm

Stryker sees its Relative Strength Rating reach the 80-plus level.


Source:Investor''s Business Daily
Why Investors Are Eyeing Stryker Corp (SYK): The Key Drivers of Market Outperformance and ...
Feb 01, 2024 15:03pm

Why Investors Are Eyeing Stryker Corp (SYK): The Key Drivers of Market Outperformance and Growth Potential


Source:GuruFocus